MedPath

Prevalence of Chronic Obstructive Pulmonary Disease in the Portuguese Population

Not yet recruiting
Conditions
Chronic Obstructive Pulmonary Disease
Registration Number
NCT06523257
Lead Sponsor
Sociedade Portuguesa de Pneumologia
Brief Summary

The EpiCOPDpt Study (Prevalence of Chronic Obstructive Pulmonary Disease in the Portuguese Population) primary objective is to estimate the prevalence of Chronic Obstructive Pulmonary Disease (COPD) in the Portuguese population aged 20 and over. It is a cross-sectional study of a representative sample of the Portuguese population aged 20 and over, using standardised post-bronchodilator spirometry. Questionnaires will be applied to collect sociodemographic, economic, clinical, and therapeutic data.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
8589
Inclusion Criteria
  • Male and female subjects aged 20 years and over, with permanent or temporary residence for at least one year in the national territory;
  • Written informed consent for study participation.
Exclusion Criteria
  • Any condition that makes it impossible to perform spirometry, in accordance with standards of the joint American Thoracic Society/European Respiratory Society, and as described in the "Contraindications for spirometry testing" section of the Study Procedures Manual;
  • Any condition that makes it impossible to perform the bronchodilation, as described in the "Contraindications for bronchodilation" section of the Study Procedures Manual;
  • Severe cognitive disability that may interfere with the person's capability to participate in the study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Individuals aged 20 years and over in the Portuguese population diagnosed with COPD(Chronic Obstructive Pulmonary Disease).Through study completion, an average of 10 months

Number and proportion of individuals aged 20 years and over in the Portuguese population diagnosed with COPD.

Secondary Outcome Measures
NameTimeMethod
Individuals aged 20 years and over in the Portuguese population diagnosed with COPD (Chronic Obstructive Pulmonary Disease), by age groupThrough study completion, an average of 10 months

Number and proportion of individuals aged 20 years and over in the Portuguese population diagnosed with COPD among males and females, within specific age groups (≥20, 20-29, 30-39, 40-49, 50-59, 60-69, and ≥70).

Individuals aged >20 years in the Portuguese population diagnosed with COPD (Chronic Obstructive Pulmonary Disease) by sexThrough study completion, an average of 10 months

Number and proportion of individuals aged 20 years and over in the Portuguese population diagnosed with COPD by sex: males and females.

Individuals diagnosed with COPD (Chronic Obstructive Pulmonary Disease) in each NUTS regionThrough study completion, an average of 10 months

Number and proportion of individuals diagnosed with COPD in each NUTS region (Norte, Centro, Lisboa e Vale do Tejo, Alentejo, Algarve, Açores, and Madeira).

Sociodemographic profile of respiratory patientsThrough study completion, an average of 10 months

A set of characteristics will be used to determine the sociodemographic profile: Sociodemographic characteristics:

* Age

* Sex

* Race

* Ethnicity

* Marital status

* Education level

* Socioeconomic status (income and living conditions) Number and proportion in case of categorical data and means, std dev and percentiles in case of continuous variables.

Clinical profile of respiratory patientsThrough study completion, an average of 10 months

A set of characteristics will be used to determine the clinical profile:

* Respiratory symptoms (such as cough, shortness of breath, and wheezing)

* Comorbidities (Yes, which?/No)

* Lung function tests (Spirometry will be carried out in accordance with the standard protocol of the joint ATS/ERS. The US Third National Health and Nutrition Examination Survey (NHANES III) values will be used as reference. Peripheral blood oxygen saturation (SpO2) will be assessed using a pulse oximeter)

* Anthropometric data: Weight in kilograms and height in meters. Weight and height will be combined to report BMI in kg/m\^2.

Number and proportion in case of categorical data and means, std dev and percentiles in case of continuous variables.

Risk profile of participantsThrough study completion, an average of 10 months

Characterisation of risk factors, such as smoking history, occupational exposures, air pollution exposure, genetic predisposition, and history of respiratory infections. Number and proportion in case of categorical data and mean, median, standard deviation, and percentiles in case of continuous variables.

© Copyright 2025. All Rights Reserved by MedPath